Preclinical modeling of combined phosphatidylinositol-3-kinase inhibition with endocrine therapy for estrogen receptor-positive breast cancer

Authors

Cesar G. Sanchez, Washington University School of Medicine in St. Louis
Cynthia X. Ma, Washington University School of Medicine in St. LouisFollow
Robert J. Crowder, Washington University School of Medicine in St. Louis
Therese Guintoli, Washington University School of Medicine in St. Louis
Chanpheng Phommaly, Washington University School of Medicine in St. Louis
Feng Gao, Washington University School of Medicine in St. LouisFollow
Li Lin, Washington University School of Medicine in St. Louis
Matthew J. Ellis, Washington University School of Medicine in St. LouisFollow

Journal

Breast Cancer Research

Publication Date

2011

Volume

13

Inclusive Pages

R21

Document Type

Open Access Publication

Rights and Permissions

Sanchez et al. Breast Cancer Research 2011, 13:R21 http://breast-cancer-research.com/content/13/2/R21

Recommended Citation

Sanchez, Cesar G.; Ma, Cynthia X.; Crowder, Robert J.; Guintoli, Therese; Phommaly, Chanpheng; Gao, Feng; Lin, Li; and Ellis, Matthew J., "Preclinical modeling of combined phosphatidylinositol-3-kinase inhibition with endocrine therapy for estrogen receptor-positive breast cancer." Breast Cancer Research. 13, R21. (2011).
https://digitalcommons.wustl.edu/open_access_pubs/66